{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:10:00Z","timestamp":1775005800065,"version":"3.50.1"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T00:00:00Z","timestamp":1366243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Andrology"],"published-print":{"date-parts":[[2013,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Hypogonadism, which is highly prevalent in men with sickle cell disease (<jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content>), affects quality of life and causes great morbidity. The safety of testosterone replacement therapy (<jats:styled-content style=\"fixed-case\">TRT<\/jats:styled-content>) in <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> in relation to priapism episodes is relatively unknown. Our aim was to monitor the safety of <jats:styled-content style=\"fixed-case\">TRT<\/jats:styled-content> in a cohort of seven hypogonadal men with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content>. Testosterone undecanoate (<jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>ebido) 1\u00a0g was administered intramuscularly to adult men with homozygous <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> (Hb <jats:styled-content style=\"fixed-case\">SS<\/jats:styled-content>) having hypogonadism [serum total testosterone \u226412.0\u00a0nmol\/L (346\u00a0ng\/dL), reference range 12.5\u201338.1\u00a0nmol\/L (360\u20131098\u00a0ng\/dL)] for 12\u00a0months. Serum total testosterone, haemoglobin, haematocrit, renal and liver function tests, glucose and <jats:styled-content style=\"fixed-case\">PSA<\/jats:styled-content> measurements were done at baseline and 12\u2010month follow\u2010up. Trough serum total testosterone, haemoglobin and haematocrit were measured three monthly. Priapism events and adverse drug events were assessed every 3\u00a0months. International Index of Erectile Function (<jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>), Androgen Deficiency in the Ageing Male (<jats:styled-content style=\"fixed-case\">ADAM<\/jats:styled-content>) and World Health Organization Quality of Life (<jats:styled-content style=\"fixed-case\">WHOQOL<\/jats:styled-content>) questionnaires were administered at baseline, 6 and 12\u00a0months. Seven men with a mean age of 34.4\u00a0years were treated. Median total testosterone increased from 10.6 to 11.2 nmol\/L (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.46). Median serum lactate dehydrogenase levels decreased from 1445 to 1143.5\u00a0IU\/L (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05), while all other laboratory indices remained stable. Injection site pain was the most frequently reported adverse event, with no increases in painful crises, hypersensitivity or oedema. After <jats:styled-content style=\"fixed-case\">TRT<\/jats:styled-content>, there was no significant increase in priapism frequency. Median questionnaire scores were increased for the <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content> (46\u201368, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.018), reduced for <jats:styled-content style=\"fixed-case\">ADAM<\/jats:styled-content> (5.0\u20132.0, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.016) and unchanged for <jats:styled-content style=\"fixed-case\">WHOQOL<\/jats:styled-content> (98\u2013103, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.086). <jats:styled-content style=\"fixed-case\">TRT<\/jats:styled-content> using testosterone undecanoate with eugonadal intent for hypogonadism appears to be safe in men with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content>. This treatment does not appear to promote priapism occurrences and rather it possibly improves sexual function. Future prospective evaluations in larger groups of hypogonadal men with <jats:styled-content style=\"fixed-case\">SCD<\/jats:styled-content> are necessary to confirm these findings.<\/jats:p>","DOI":"10.1111\/j.2047-2927.2013.00084.x","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T02:43:47Z","timestamp":1366339427000},"page":"576-582","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12\u2010month safety report"],"prefix":"10.1111","volume":"1","author":[{"given":"B. F.","family":"Morrison","sequence":"first","affiliation":[{"name":"Department of Surgery University of the West Indies Mona Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reid","sequence":"additional","affiliation":[{"name":"Sickle Cell Unit University of the West Indies Mona Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Madden","sequence":"additional","affiliation":[{"name":"Sickle Cell Unit University of the West Indies Mona Jamaica"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Burnett","sequence":"additional","affiliation":[{"name":"James Buchanan Brady Urological Institute Johns Hopkins Medical Institutions Baltimore MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,18]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-5-601"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031719"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-75"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2354"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-3012"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.10.061"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2011.02288.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2006.00270.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ucl.2007.08.006"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.10.3.445"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12059"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0407183102"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0447"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(80)90469-6"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8201"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743\u20106109.2012.02808.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820401)49:7<1373::AID-CNCR2820490712>3.0.CO;2-G"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0272.2011.01192.x"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2373"},{"key":"e_1_2_8_21_1","first-page":"1001","article-title":"Priapism following testosterone therapy for delayed puberty","volume":"143","author":"Key LL","year":"1989","journal-title":"Am J Dis Child"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1970.tb01919.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/oxfordjournals.humrep.a136051","article-title":"Tolerability of intramuscular injections of testosterone ester in oil vehicle","volume":"10","author":"Mackey MA","year":"1995","journal-title":"Hum Reprod"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199911000-00013"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(01)00420-1"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000087608.07371.ca"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2010.01765.x"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1699"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2000.8625"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-012-0258-9"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(75)80662-7"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90525-0"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.736.95"},{"key":"e_1_2_8_34_1","first-page":"12","article-title":"The mechanism of low testosterone levels in homozygous sickle\u2010cell disease","volume":"43","author":"Parshad O","year":"1994","journal-title":"West Indian Med J"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.110.011890"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/clinchem\/21.4.582","article-title":"Zinc deficiency in sickle cell disease","volume":"21","author":"Prasad AS","year":"1975","journal-title":"Clin Chem"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00238-0"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/471584"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.06756.x"},{"key":"e_1_2_8_40_1","first-page":"3","volume-title":"Sickle Cell Disease","author":"Serjeant GR","year":"2001"},{"key":"e_1_2_8_41_1","first-page":"20","article-title":"Testosterone deficiency and extreme retardation of puberty in homozygous sickle\u2010cell disease","volume":"44","author":"Singhal A","year":"1995","journal-title":"West Indian Med J"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.1995.8.3.199"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.00094.x"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.2164\/jandrol.109.009597"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291798006667"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-006-0120-0"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)67836-6"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(88)80364-4"},{"key":"e_1_2_8_49_1","article-title":"IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men","author":"Zitzmann M","year":"2012","journal-title":"J Sex Med"},{"key":"e_1_2_8_50_1","first-page":"209","article-title":"Nitric oxide mediated erectile activity is a testosterone dependent event: a rat erection model","volume":"7","author":"Zvara P","year":"1995","journal-title":"Int J Impot Res"}],"container-title":["Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2047-2927.2013.00084.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.2047-2927.2013.00084.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:55:29Z","timestamp":1698659729000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.2047-2927.2013.00084.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["10.1111\/j.2047-2927.2013.00084.x"],"URL":"https:\/\/doi.org\/10.1111\/j.2047-2927.2013.00084.x","archive":["Portico"],"relation":{},"ISSN":["2047-2919","2047-2927"],"issn-type":[{"value":"2047-2919","type":"print"},{"value":"2047-2927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]},"assertion":[{"value":"2012-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-02-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-04-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}